The winds have changed: just when we thought Olym­pus was­n’t going any­where any time soon, the com­pa­ny’s CEO Yasuo Takeuchi has told reporters that there could be some major changes on the way. Accord­ing to a Bloomberg report, the com­pa­ny is plan­ning on restruc­tur­ing “in due course” – which could involve job cuts – to meet its busi­ness goals. 

Although Takeuchi did­n’t spec­i­fy exact­ly which part of the mul­ti­fac­eted busi­ness would see the restruc­tur­ing, he did fol­low it up by sug­gest­ing there is a pos­si­bil­i­ty Olym­pus may con­sid­er sell­ing the cam­era divi­sion.

Every time rumors sur­face about Olym­pus shut­ting down its imag­ing arm – some­thing that typ­i­cal­ly hap­pens at least once a year – pun­dits say that the Japan­ese cam­era mak­er will sell that side of its busi­ness. And each time Olym­pus has stood firm, stat­ing that the cam­era divi­sion isn’t for sale.

While this admis­sion may be dis­ap­point­ing to many (us includ­ed), it does make sense from a busi­ness per­spec­tive. As Bloomberg points out, the imag­ing arm accounts for just 6% of the com­pa­ny’s sales, with the low­est mar­gins and low­est gains. 

Takeuchi said that the com­pa­ny will peri­od­i­cal­ly reassess its port­fo­lio in order to focus on its med­ical divi­sion. After all, Olym­pus does con­trol 70% of the glob­al endo­scope sup­ply.

That said, sell­ing the cam­era arm is still only a thought at the moment, with no firm plans in place yet.

Source link